1/4
Export Ready

Lucrin Depot 3.75 mg / 11.25 mg Injection

Sold by melizza lifescience · Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Price
Price on request
In stock
Inclusive of all taxes
Minimum order: 1 Centimetre

Export Snapshot

MOQ
1 Centimetre
Lead time
On request
Packaging
Standard export packaging
Shelf life / longevity
As per product specification
HS Code
On request
Origin
India
Port of dispatch
On request
Export markets served
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
Values shown are for melizza lifescience.
Compliance & Certifications
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

melizza lifescience is a Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup based in Rajkot Gujarat India.

Rajkot Dispatch on request Verified seller
melizza lifescience logo

melizza lifescience

Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup · Rajkot, Gujarat, India

Registered address: Rajkot, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
Not shared
Employees
–
GST
24GQFPM5460R1Z4
IEC code
GQFPM5460R
Export markets
Algeria flag DZ Andorra flag AD Anguilla flag AI Angola flag AO Argentina flag AR +47 others
GlobalLinker Member Since
Aug 2025
Turnover
Incorporation Type
On request
Verified Seller
Product details

What are the specifications of this product?

Overview

Product Name: Lucrin Depot 3.75 mg / 11.25 mg InjectionManufacturer: Abbott / AbbVieGeneric Name: Leuprolide Acetate Therapeutic Category: Hormonal Therapy / Gonadotropin-Releasing Hormone (GnRH) Agonist Product Description: Lucrin Depot is a long-acting injectable formulation of Leuprolide Acetate, a synthetic analogue of gonadotropin-releasing hormone (GnRH). It is widely used in the treatment of hormone-dependent conditions, particularly prostate cancer, endometriosis, and uterine fibroids. By continuously stimulating the pituitary gland, Leuprolide suppresses the release of gonadotropins (LH and FSH), leading to decreased production of sex hormones (testosterone in men, estrogen in women). Available Strengths: • Lucrin Depot 3.75 mg Vial – 1-month depot injection • Lucrin Depot 11.25 mg Vial – 3-month depot injection Indications: • Advanced prostate cancer (androgen-dependent) • Endometriosis (symptom management) • Uterine fibroids (preoperative management) • Central Precocious Puberty (CPP) in children

Product Description

Dosage & Administration:
• Intramuscular (IM) or Subcutaneous (SC) injection once every month (3.75 mg) or once every 3 months (11.25 mg).
• Administered by a healthcare professional.
• Dosage schedule depends on indication and patient condition.

Key Benefits:
• Provides effective hormonal suppression.
• Long-acting depot formulation ensures steady hormone control.
• Improves symptoms and delays disease progression in hormone-dependent cancers and disorders.

Packaging:
• Vial with sterile diluent for reconstitution.
• Single-use pack (3.75 mg or 11.25 mg).

Storage:
• Store at 2°C – 8°C (Refrigerated).
• Protect from light.
• Do not freeze.

Important Notes:
• For use under strict medical supervision only.
• Initial treatment phase may cause a temporary surge in hormones (tumor flare in prostate cancer).
• Not recommended in pregnancy or breastfeeding.
• Regular monitoring of hormone levels, bone health, and disease progression is necessary.

Description provided by melizza lifescience.

Specifications

Generic Name Leuprolide Acetate
Therapeutic Category Hormonal Therapy / GnRH Agonist
Indications Advanced prostate cancer, endometriosis, uterine fibroids, central precocious puberty
Dosage Form Injection (Depot)
Injection Type Intramuscular (IM) or subcutaneous (SC)
Dosage Strengths 3.75 mg and 11.25 mg per vial
Frequency of Administration Monthly or every 3 months
Storage Requirements Refrigerate at 2°C – 8°C, away from light, avoid freezing
Packaging Details Single-use vial with sterile diluent for reconstitution
Contraindications Pregnancy, breastfeeding
Precautions Must be administered by healthcare professionals; monitor hormone levels and bone health
Adverse Effects Warning Initial hormone surge (tumor flare) in prostate cancer patients possible

Use cases

Category Pharmaceuticals > Hormonal & Endocrine Therapy > Gonadotropin-Releasing Hormone (GnRH) Agonists > Leuprolide Acetate Injections
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging As per buyer requirement
Storage condition As recommended by supplier
Origin India
Form As listed by supplier

Commercials (this seller)

Minimum order 1 Centimetre
Lead time On request
Payment terms As per negotiated commercial agreement.
Checkout type enquiry
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Lucrin Depot 3.75 mg / 11.25 mg Injection. Answers compiled from verified sellers' commercial terms and platform data.

Q: What are the main differences between the 3.75 mg and 11.25 mg Lucrin Depot injections in terms of dosing schedule?
A: The Lucrin Depot 3.75 mg injection is designed for monthly administration, whereas the 11.25 mg injection is formulated for administration every three months, providing greater dosing convenience depending on patient needs.
Q: How does Lucrin Depot achieve hormonal suppression in patients with hormone-dependent diseases?
A: Lucrin Depot works as a GnRH agonist by continuously stimulating the pituitary gland, which paradoxically suppresses the release of LH and FSH hormones, leading to reduced production of testosterone and estrogen. This hormonal suppression helps in controlling the progression of diseases like prostate cancer and endometriosis.
Q: What precautions should be taken during the initial phase of treatment with Lucrin Depot for prostate cancer patients?
A: During the initial treatment phase, Lucrin Depot may cause a temporary surge in testosterone levels (tumor flare), which can worsen symptoms. Close medical supervision and possibly adjunct therapies are essential to manage this effect safely.
Q: Can Lucrin Depot injections be administered by healthcare professionals in outpatient settings?
A: Yes, Lucrin Depot injections are intended to be administered by qualified healthcare professionals via intramuscular or subcutaneous injection, making them suitable for use in outpatient clinics or hospital settings.
Q: What storage conditions are necessary to maintain the efficacy of Lucrin Depot injections?
A: Lucrin Depot injections must be refrigerated at temperatures between 2°C and 8°C, protected from light, and should never be frozen to ensure stability and potency.
Question not answered? Ask sellers directly — typical response within 4 hours.

What similar products are available in this category?

Browse all in category
View all →
remtrex 2.5mg, 15mg,
remtrex 2.5mg, 15mg,
Price on request MOQ 1 Centimetre
View Product
erlocip 150mg
erlocip 150mg
Price on request MOQ 1 Centimetre
View Product
gemdronic 5mg
gemdronic 5mg
Price on request MOQ 1 Centimetre
View Product
gemdronic 5mg
gemdronic 5mg
Price on request MOQ 1 Centimetre
View Product
altanib nova imatinib 400mg tablets
altanib nova imatinib 400mg tablets
Price on request MOQ 1 Centimetre
View Product
truvada-tablets
truvada-tablets
Price on request MOQ 1 Centimetre
View Product
abstet 250mg tablet (abiraterone acetate (250mg))
abstet 250mg tablet (abiraterone acetate (250mg))
Price on request MOQ 1 Piece
View Product
syringe glycerine
syringe glycerine
Price on request MOQ 1 Centimetre
View Product
Lucrin Depot 3.75 mg / 11.25 mg Injection
Lucrin Depot 3.75 mg / 11.25 mg Injection
Price on request · MOQ 1Centimetre